Navigation Links
Hormone refractory prostate cancers more likely to spread to other organs
Date:2/20/2008

ally, doctors dont like to use hormone treatment which stops the production of testosterone - early on in the treatment of prostate cancer because of the harsh side effects, which can include hot flashes, osteoporosis and sexual dysfunction. In the past, doctors have waited until the cancer spread to prescribe hormone therapy, Reiter said.

This study may provide additional scientific rationale to support the recent trend that giving hormone treatment early on is better than waiting, Reiter said. Early hormone treatment in this group of men might allow them to live longer. High levels of androgen receptor in the primary tumor might also predict which cancers are more likely to spread despite initial surgery or radiation.

This strategy could be particularly effective in high risk men, those with large primary tumors, high Gleason scores and those that have lymph node involvement at diagnosis.

Prostate cancer is the most common cancer in men in the United States. This year alone, more than 218,000 men will be diagnosed with prostate cancer. About 27,000 men will die from the disease.

Reiter and his team will next seek to understand the mechanism by which androgen receptor overexpression is causing the cancer to spread. If they can uncover the mechanism, they might find new and better targets for drug therapy in addition to targeting the androgen receptor.


'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Newly discovered role of thyroid hormone during pregnancy
2. Stress hormone impacts memory, learning in diabetic rodents
3. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
4. Diabetes, Growth Disorders Drive Sales of Pediatric Hormone Drugs
5. Sex Hormones Dont Seem to Affect Prostate Cancer Risk
6. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
7. FDA Warns Against Bio-Identical Hormone Therapy
8. FDA Asserts New Policy to Restrict Womens Access to Bioidentical Hormones
9. Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
10. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
11. Hormone may be new drug target for preventing lymphedema, tumor spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Albany, NewYork (PRWEB) February 27, 2015 ... recent study that presents the analysis of the ... globe. The research report discusses the current scenario ... protein surface coating industry for the period of ... TOC @ http://www.researchmoz.us/global-cell-culture-protein-surface-coating-market-2015-2019-report.html , The research ...
(Date:2/27/2015)... 2015 Qualis Health, one of ... been named a finalist in the 6th Annual ... outstanding commitment toward continuous improvement in care transitions. ... hospital readmission rates through its Communities for Safer ... to receive this national recognition, which demonstrates Qualis ...
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 UAS ... Adult Cubes, at Natural Products Expo West, March 6 ... are very excited to release the hands down best ... cream taste with an extra zing of Vitamin C. ... Cubes, winner of the NutrAward 2014, Delicious Living’s Supplement ...
(Date:2/27/2015)... Austin, TX (PRWEB) February 27, 2015 ... University 3D printing survey is to explore the current ... economy. You are invited to contribute to the Survey ... Preliminary results reveal varied use among large and ... categories of companies. In a recent PwC and Manufacturing ...
(Date:2/27/2015)... Marketresearchreports.biz has announced the addition of ... of market studies that presents an analysis of the ... 2015-2019. The research report talks about the current market ... devices industry across the globe. , According to the ... the global sports medicine devices market is likely to ...
Breaking Medicine News(10 mins):Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 2Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 3Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 3Health News:Global Sports Medicine Devices Market Benefitting from Significant Contribution from Arthroscopy Segment: MarketResearchReports.Biz 2Health News:Global Sports Medicine Devices Market Benefitting from Significant Contribution from Arthroscopy Segment: MarketResearchReports.Biz 3
... moderate to severe disease , , MONDAY, April 28 (HealthDay ... human eye into areas of the brain damaged by ... improve quality of life in people with moderate to ... symptoms experienced when people were off their Parkinson,s medications ...
... WashingtonResearch on traumatic spinal cord injuries is hampered by ... human outcomes, says a new study in the upcoming ... The review was written by scientists with the Physicians ... animal experiments, we still dont have a drug to ...
... /PRNewswire-FirstCall/ - SXC Health Solutions,Corp. ("SXC" or the "Company") ... pharmacy benefits management services, announces that it has been,notified ... leading competitive,bid to be considered for the awarding of ... While there is no assurance as to when, if ...
... 28 Depression is a serious but,treatable health ... men.,This condition will be the focus of a ... called Men Get Depression, which is,supported by the ... the nation,s largest health benefits company., The ...
... In observation of,"National Volunteer Week," Health Secretary ... for giving their time to ensure,communities are prepared ... Week is April 27 through May 3., ... response -,from providing medical care and preparing meals ...
... UCLA Orthopedic Hospital, has been chosen as the recipient ... of Alzheimers Disease in recognition of his outstanding work, ... immunity in Alzheimers disease" by M. Fiala, D.H. Cribbs, ... 457-63). Each year the Associate Editors of the journal ...
Cached Medicine News:Health News:Eye Cell Implants Improve Parkinson's Symptoms 2Health News:Eye Cell Implants Improve Parkinson's Symptoms 3Health News:Spinal cord injury research hampered by animal models, says new study 2Health News:WellPoint Foundation Supports National Campaign Focused on Depression Among Men 2Health News:WellPoint Foundation Supports National Campaign Focused on Depression Among Men 3Health News:Pennsylvania's Volunteers Commended During 'National Volunteer Week' 2Health News:Milan Fiala, MD, receives 2008 Alzheimer Award 2
(Date:2/26/2015)... , Feb. 26, 2015  CSSi, ( ... for the clinical research industry, is pleased to ... as a Project Manager, adding significant value ... Photo - http://photos.prnewswire.com/prnh/20150225/177750 ... a demonstrated ability to successfully lead the navigation ...
(Date:2/26/2015)... February 26, 2015 Editor ... to bottom . Investor-Edge has initiated coverage ... JNJ ), Teva Pharmaceutical Industries Ltd (NYSE: ... ENDP ), Allergan Inc. (NYSE: AGN ), ... research report on Johnson and Johnson can be accessed ...
(Date:2/26/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... and Company 35 th Annual Health Care Conference on ... the Boston Marriott Copley Place. A live webcast of the ... will be available approximately one hour after the presentation. ...
Breaking Medicine Technology:CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
... Drugs Target Gene Pathways to Preserve Heart, Possibly ... Researchers at The,Children,s Hospital of Philadelphia have manipulated ... flow to strongly protect heart,tissue in animal studies. ... treatment for heart attack patients, particularly since already,existing ...
... Clinical Utility of Modigene,s CTP Technology for Extending ... the Duration of Action of Therapeutic Proteins -, ... Board: MODG) today noted the successful completion of a ... alfa (FSH-CTP). FSH-CTP uses the naturally occurring CTP,peptide to ...
Cached Medicine Technology:Novel Approach May Protect Against Heart Attack Injury 2Novel Approach May Protect Against Heart Attack Injury 3Modigene Platform Validated in Independent Phase III Trial of CTP Technology 2Modigene Platform Validated in Independent Phase III Trial of CTP Technology 3